Drug Trial Radar · NCT00889330
Safety and Efficacy Study of a Eye Drop for Eye Allergy
Last checked: Nov 20, 2026Latest source record: Mar 6, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
60
Actual
Start
Apr 2009
Primary completion
May 2009
Sponsor
- Lead sponsor
- Vistakon PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Apr 28, 2009
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 10 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and safety of an anti-allergy eyedrop.
Conditions
- Allergic Conjunctivitis
Interventions
alcaftadineDrug
0.25% Ophthalmic Solution, one drop in each eye at each of two visits.
PlaceboDrug
Vehicle without active, one drop in each eye at each of two visits.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Ocular Itching at Visit 3 (Day 0) at 7 Minutes Following Allergen Challenge, 16 Hours After Treatment Instillation.Time frame: Visit 3 (Day 0) 16 hours post-dose, at up to 7 minutes following Allergen Challenge
- Conjunctival Redness at Visit 3 (Day 0) at 20 Minutes Following Allergen Challenge, 16 Hours After Treatment InstillationTime frame: Visit 3 (Day 0) At 20 minutes following Allergen Challenge, 16 hours post-treatment
- Ocular Itching at Visit 4 (Day 14) at 7 Minutes Following Allergen Challenge, 15 Minutes Post- Treatment InstillationTime frame: Visit 4 (Day 14) up to 7 minutes following Allergen Challenge
- Conjunctival Redness at Visit 4 (Day 14) at 20 Minutes Following Allergen Challenge, 15 Minutes Post Treatment InstillationTime frame: Visit 4 (Day 14) At 20 minutes following Allergen Challenge
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Site not named
Fairfield, Ohio
Site not named
Mason, Ohio
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.